Compare Liquidia Corporation Common Stock (LQDA) vs Intuitive Machines (LUNR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Intuitive Machines — how do they compare? Liquidia Corporation Common Stock trades at $33.5 (market cap $2.40B), while Intuitive Machines trades at $10.79 (market cap $1.97B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Intuitive Machines is more actively traded (6,024,737 versus 2,857,547). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Intuitive Machines for 7 Days on average.
| LQDA | LUNR | |
|---|---|---|
Market Cap | $2.40B | $1.97B |
Volume | 2,857,547 | 6,024,737 |
Sector | Health | Industrials |
52-Week High | $91.03 | $45.70 |
52-Week Low | $22.02 | $8.05 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $2.30B | $2.04B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Intuitive Machines (LUNR) trades at $12.18, down 5.29% on the day, reflecting a bearish technical trend. The company is in a high-growth phase, with revenue projected to surge from $207 million in 2025 to $481 million in 2026, but it remains deeply unprofitable with a net loss margin of -27.1%. Recent news highlights its strategic position in lunar infrastructure and satellite manufacturing, supported by NASA contracts, though the stock faces pressure from broader sector weakness.
The investment case hinges on execution of its growth strategy amid significant cash burn. Analyst consensus is strongly bullish with an $31.33 price target, but high execution risk and persistent losses present a speculative opportunity. Key risks include dependence on government contracts and intense competition in the space sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Intuitive Machines
Intuitive Machines provides lunar access, data, and infrastructure services. Its capabilities include lunar landers, communications systems, and technologies designed to support missions to the Moon.
Read more on LUNR →
